Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Journal of Medical Economics|August 18, 2023
Meta-regression to explain the placebo effects in clinical trials of anti-CGRP monoclonal antibodies for migraine preventionStephane Alexandre Regnier, Xin Ying Lee
Clinicoeconomics and Outcomes Research : CEOR|January 27, 2021
Long-Term Outcomes of Previously Treated Adult and Adolescent Patients with Severe Hemophilia A Receiving Prophylaxis with Extended Half-Life FVIII Treatments: An Economic Analysis from a United Kingdom PerspectiveGary Benson, Tim Morton, Huw Thomas, et al.
Clinical and Experimental Gastroenterology|October 28, 2016
Systematic review: treatment pattern and clinical effectiveness and safety of pharmaceutical therapies for Crohn's disease in EuropeFilippo Lelli, Solomon Nuhoho, Xin Ying Lee, et al.
Behavior Research Methods|January 16, 2026
Unconscious cognition without post hoc selection artifacts: From selective analysis to functional dissociationsThomas Schmidt, Maximilian P Wolkersdorfer, Xin Ying Lee, et al.
Current Medical Research and Opinion|May 25, 2017
Dose escalation of biologics in Crohn's disease: critical review of observational studiesThomas R Einarson, Basil G Bereza, Xin Ying Lee, et al.
Neurology and Therapy|September 20, 2023
Burden of Medication Overuse in Migraine: A Cross-sectional, Population-Based Study in Five European Countries Using the 2020 National Health and Wellness Survey (NHWS)Agnete Skovlund Dissing, Xin Ying Lee, Ole Østerberg, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 19, 2018
Diabetes Management and Healthcare Resource Use When Intensifying from Basal Insulin to Basal-Bolus: A Survey of Type 2 Diabetes PatientsKathryn M Pfeiffer, Amaury Basse, Xin Ying Lee, et al.
Diabetes, Obesity & Metabolism|May 26, 2018
The management of type 2 diabetes with fixed-ratio combination insulin degludec/liraglutide (IDegLira) versus basal-bolus therapy (insulin glargine U100 plus insulin aspart): A short-term cost-effectiveness analysis in the UK settingRussell Drummond, Samuel Malkin, Michelle Du Preez, et al.
Patient Preference and Adherence|July 30, 2019
Real-world utilities and health-related quality-of-life data in hemophilia patients in France and the United KingdomLiz Carroll, Gary Benson, Jérémy Lambert, et al.
Journal of Comparative Effectiveness Research|May 24, 2023
Comparison of indirect treatment methods in migraine prevention to address differences in mode of administrationChristopher G Fawsitt, Howard Thom, Stephane A Regnier, et al.
Pageof 3